Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

COSCIENS Biopharma Inc T.AEZ


Primary Symbol: T.AEZS

COSCIENS Biopharma Inc., formerly Aeterna Zentaris Inc., is a specialty biopharmaceutical company engaged in the development and commercialization of a diverse portfolio of pharmaceutical and diagnostic products, including those focused on areas of unmet medical need. Its lead product, macimorelin (Macrilen; Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone deficiency (AGHD). The Company is also engaged in the development of therapeutic assets and proprietary extraction technology, which is applied to the production of active ingredients from renewable plant resources used in cosmeceutical products (i.e., oat beta glucan and avenanthramides, which are found in skincare product brands like Aveeno and Burt’s Bees formulations) and being developed as potential nutraceuticals and/or pharmaceuticals.


TSX:AEZS - Post by User

Bullboard Posts
Comment by purehellon Nov 20, 2015 11:37pm
98 Views
Post# 24311686

RE:Shares

RE:SharesHere is what I received when I asked a good friend for the info. 

...........
"Here:

New # of shares: 6.336M shares
Market cap: 34.12 M
Close price today: $5.39
Day High/Low: 5.39/4.33
52 Week High/Low: 110.00/5.50

Since we closed at the top end of a wide trading range, and the sentiment is at rock bottom, key technical indicators indicated this might be good jump off point.  Since funds and large investor restricted to buy sub $1 stock can now purchase this stock, they will after looking at the potential of the stock in this pharma market cycle.   Small pharma buyout as to be expected. ".
...............

If you have any questions, I'll pass them on. I was able to  buy just below $5.  I had to change my limit order to market order since I kept missing it and the price was going higher and higher from the lows.

For those who suffered this journey down, I'm sure it was pure hell.  Fortunately, my buddy is 95% convinced this the bottom, that's good news.  I'll ask him for more info if anyone is interested.
Bullboard Posts